Modesto, CANCT06029270Now EnrollingIRB Ready

Nasopharyngeal Cancer Clinical Trial in Modesto, CA

Access cutting-edge nasopharyngeal cancer treatment through this clinical trial at a research site in Modesto. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this Modesto location

Preparing your pre-screening questions...

Expert Care in Modesto

Access nasopharyngeal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nasopharyngeal cancer treatment provided free

Apply for This Modesto Location

Check if you qualify for this nasopharyngeal cancer clinical trial in Modesto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Modesto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Modesto site if eligible
  4. 4Begin participation

About This Nasopharyngeal Cancer Study in Modesto

This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to other places in the body (metastatic). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. The usual approach of treatment is initial treatment with chemotherapy such as the co

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

PRIOR TO STEP 1 REGISTRATION:
Pathologically (histologically or cytologically) proven diagnosis of nasopharyngeal carcinoma (NPC) that has recurred locoregionally and/or is present at distant sites. Patients who present with metastatic disease (de novo) at diagnosis are also eligible. For locoregional recurrence, the disease must not be amenable to potentially curative surgery or re-irradiation. Eligible patient must have the following characteristics:
Tumor showing (histological/cytological) Epstein-Barr encoded ribonucleic acid (EBER)-positivity (e.g., In situ hybridization, immunohistochemistry) or
A known history of detectable plasma EBV DNA (via a polymerase chain reaction \[PCR\]-based assay) at any time point since the initial diagnosis of NPC.
Measurable disease as defined by RECIST 1.1 criteria. Lesion(s) that have been irradiated previously can be counted as measurable as long as radiological progression after the prior radiation therapy ha

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Modesto?

Yes, this clinical trial (NCT06029270) has an active research site in Modesto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nasopharyngeal Cancer Treatment Options in Modesto, CA

If you're searching for nasopharyngeal cancer treatment options in Modesto, CA, this clinical trial (NCT06029270) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Modesto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasopharyngeal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all nasopharyngeal cancer clinical trials near you to find additional studies recruiting in your area.

More Head and Neck Cancer Trials in Modesto, CA

See all head and neck cancer clinical trials recruiting in Modesto — not just this study.

Browse Head and Neck Cancer Trials in Modesto

Ready to Join in Modesto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Modesto, CA